Aphase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605

Mikkael A. Sekeres, Holly Gundacker, Jeffrey Lancet, Anjali Advani, Stephen Petersdorf, Jane Liesveld, Deborah Mulford, Tom Norwood, Cheryl L. Willman, Frederick R. Appelbaum, Alan F. List

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Aphase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds